Contact us

Research

European Young Chemists' Network Representative

Shona Richardson, a 2nd year PhD student in the Campopiano group, has been selected as one of two Royal Society of Chemistry representatives on the European Young Chemists' Network (EYCN).

Her first job will be to present her biocatalysis work at the EYCN 2020 event in Sitges, Spain in January. Over the next two years Shona will build networks with other young chemists from across Europe.

Congratulations to Shona!

£2.75 million spinout deal offers dialysis hope

Dialysis technology company Invizius has secured funding from a consortium of investors including Mercia Asset Management and the University’s own venture investment fund, Old College Capital.

Invizius stems from years of research by Dr Andy Herbert and his team in the University’s School of Chemistry. In May 2018 he co-founded Invizius and became the Chief Technology Officer at the company.

Reducing risk

The researchers believe they have found a way to reduce the risk of cardiovascular disease among patients undergoing long-term dialysis.

Continued Support for Horrocks Group

The Horrocks Group are once again extremely grateful for a donation made by Dr. Jim Love to support their research into neurodegenerative diseases. His previous gift helped to fund a single-molecule microscope that is currently being used to look at protein "clumps" that are formed in Alzheimer's and Parkinson's diseases. His second gift will be used to continue this important work, and will allow Owen Kantelberg, a second year Ph.D.

New Paper Published

Research carried out by Professor Colin Campbell's group, with collaborators in the University of Edinburgh's School of Biology, Jerusalem and Liege has recently been published online in the Proceedings of theNational Academy of Sciences of the United States of America. The paper is titled "Intracellular redox potential is correlated with miRNA expression in MCF7 cells under hypoxic conditions ".